The Ki67 scores (22.4 ± 21.2 vs. 33.4 ± 22.1; p = 0.002) were lower in the EGFR-mutant NSCLC patients than in the EGFR wild-type patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.